These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7572963)

  • 21. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug injecting and HIV infection: new directions for social science research.
    Stimson G
    Int J Addict; 1992 Feb; 27(2):147-63. PubMed ID: 1544721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada.
    Roy E; Richer I; Morissette C; Leclerc P; Parent R; Claessens C; Blanchette C; Alary M
    AIDS; 2011 Sep; 25(15):1897-903. PubMed ID: 21785319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993.
    Prevots DR; Allen DM; Lehman JS; Green TA; Petersen LR; Gwinn M
    Am J Epidemiol; 1996 Apr; 143(7):733-42. PubMed ID: 8651236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The validity of self-reported HIV antibody test results.
    McCusker J; Stoddard AM; McCarthy E
    Am J Public Health; 1992 Apr; 82(4):567-9. PubMed ID: 1546774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streets, drugs, and the economy of sex in the age of AIDS.
    Weeks MR; Grier M; Romero-Daza N; Puglisi-Vasquez MJ; Singer M
    Women Health; 1998; 27(1-2):205-29. PubMed ID: 9640643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam.
    Hartgers C; van den Hoek A; Krijnen P; Coutinho RA
    Am J Public Health; 1992 Apr; 82(4):547-51. PubMed ID: 1312311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multisite study of sexual orientation and injection drug use as predictors of HIV serostatus in out-of-treatment male drug users.
    Deren S; Estrada A; Stark M; Williams M; Goldstein M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(4):289-95. PubMed ID: 9292588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group.
    Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV infection and patterns of risk among women drug injectors and crack users in low and high sero-prevalence sites.
    Tortu S; Beardsley M; Deren S; Williams M; McCoy HV; Stark M; Estrada A; Goldstein M
    AIDS Care; 2000 Feb; 12(1):65-76. PubMed ID: 10716019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.
    Des Jarlais DC; Perlis T; Friedman SR; Deren S; Chapman T; Sotheran JL; Tortu S; Beardsley M; Paone D; Torian LV; Beatrice ST; DeBernardo E; Monterroso E; Marmor M
    Am J Public Health; 1998 Dec; 88(12):1801-6. PubMed ID: 9842377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II.
    Des Jarlais DC; Perlis TE; Stimson GV; Poznyak V;
    BMC Public Health; 2006 Mar; 6():54. PubMed ID: 16512922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesbian and bisexual women in small cities--at risk for HIV? HIV Prevention Community Collaborative.
    Norman AD; Perry MJ; Stevenson LY; Kelly JA; Roffman RA
    Public Health Rep; 1996; 111(4):347-52. PubMed ID: 8711103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
    Battjes RJ; Pickens RW; Brown LS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):90-6. PubMed ID: 7648291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
    Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
    Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in human immunodeficiency virus seropositivity and seroconversion in US Navy enlisted personnel: 1986 to 1989. Navy HIV Working Group.
    Garland FC; Gorham ED; Cunnion SO; Miller MR; Balazs LL
    Am J Public Health; 1992 Apr; 82(4):581-4. PubMed ID: 1546779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.